Worth reading
34Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
28
¥100 million (year-on-year decrease in operating profit)Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportThird quarter of the fiscal year ending October 20267 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,414 million+5.0%
Operating profit¥76 million-27.0%
Ordinary income¥122 million+6.0%
Net income¥57 million-37.0%
Full-year earnings forecast
Net Sales
¥1,750 million
Operating profit
¥27 million
Ordinary income
¥85 million
Profit attributable to owners of the parent
¥40 million
Agrochemicals and agriculture-related products
¥1,370 million
Chemical Products
¥290 million
Other
¥90 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Year-on-Year Revenue Growth¥69 million
- Year-on-year decline in operating income¥-28 million
- Year-on-year increase in ordinary income¥6 million
- Year-on-year decrease in net income attributable to owners of the parent¥-33 million
- Increase in the full-year revenue forecast from the previous forecast¥130 million
- Decrease in the full-year operating income forecast from the previous forecast¥-45 million
- Decrease in the full-year ordinary income forecast from the previous forecast¥-24 million
- Decrease in the full-year net income forecast from the previous forecast¥-24 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Average exchange rate
Actual results¥158 per US$1
Revised full-year forecastUS$1 = ¥155
New initiatives
- Strengthening initiatives for overseas development
- Advancing research through the use of cutting-edge technologies
- Upgrading production and research facilities
Segment results
Agrochemicals and agriculture-related products
Net Sales
¥1,119 million+3.0%
Operating profit
¥68 million-32.0%
Chemical Products
Net Sales
¥225 million+20.0%
Operating profit
¥19 million+31.0%
Other
Net Sales
¥70 million-7.0%
Operating profit
¥6 million+14.0%
Capital expenditures
¥60 100 million FY2026 forecast
Annual Dividend
¥24 per share
Interim10
End of period14
Payout ratio
72.3 %
TargetAt least 30%
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Third quarter of the fiscal year ending October 2026 |
| Net Sales | ¥1,414 million (YoY +5.0%) |
| Operating profit | ¥76 million (YoY -27.0%) |
| Ordinary income | ¥122 million (YoY +6.0%) |
| Net income | ¥57 million (YoY -37.0%) |
| Full-year earnings forecast | Net Sales ¥1,750 million / Operating profit ¥27 million / Ordinary income ¥85 million / Profit attributable to owners of the parent ¥40 million / Agrochemicals and agriculture-related products ¥1,370 million / Chemical Products ¥290 million / Other ¥90 million |
| Segment results | Agrochemicals and agriculture-related products Net Sales ¥1,119 million (YoY +3.0%) / Operating profit ¥68 million (YoY -32.0%) / Chemical Products Net Sales ¥225 million (YoY +20.0%) / Operating profit ¥19 million (YoY +31.0%) / Other Net Sales ¥70 million (YoY -7.0%) / Operating profit ¥6 million (YoY +14.0%) |
| Breakdown of Factors Affecting the Change | Factors Year-on-Year Revenue Growth / Amount ¥69 million, Factors Year-on-year decline in operating income / Amount ¥-28 million, Factors Year-on-year increase in ordinary income / Amount ¥6 million, Factors Year-on-year decrease in net income attributable to owners of the parent / Amount ¥-33 million, Factors Increase in the full-year revenue forecast from the previous forecast / Amount ¥130 million, Factors Decrease in the full-year operating income forecast from the previous forecast / Amount ¥-45 million, Factors Decrease in the full-year ordinary income forecast from the previous forecast / Amount ¥-24 million, Factors Decrease in the full-year net income forecast from the previous forecast / Amount ¥-24 million |
| Assumptions Underlying the Business Outlook | Average exchange rate Actual results ¥158 per US$1 / Revised full-year forecast US$1 = ¥155 |
| Annual Dividend | ¥24 per share |
| Payout ratio | 72.3 % |
| Capital expenditures | ¥60 100 million (FY2026 forecast) |
| New initiatives | Strengthening initiatives for overseas development, Advancing research through the use of cutting-edge technologies, Upgrading production and research facilities |
Items this document does not state (17)
Gross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planKey KPIsUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased on higher sales in the agrochemicals and agriculture-related business and the chemicals business. Operating income declined due to inventory valuation losses recognized as market prices fell following the entry of generic competition for アクシーブ. Ordinary income increased on improvements in foreign exchange gains and losses and equity-method investment gains, while net income declined due to impairment losses on fixed assets in the chemicals business and structural reform expenses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.